Dermatitis, Eczematous Terminated Phase 1 Trials for Anakinra (DB00026)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01122914A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic DermatitisTreatment